{"id":"W2027863730","doi":"10.1177/1076029609343004","title":"Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor","year":2009,"lang":"en","type":"review","venue":"Clinical and Applied Thrombosis/Hemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Direct thrombin inhibitor; Pharmacokinetics; Pharmacodynamics; Pharmacology; Discovery and development of direct thrombin inhibitors; Thrombin time; Atrial fibrillation; Rivaroxaban; Anesthesia; Warfarin; Internal medicine; Thrombin; Coagulation; Partial thromboplastin time","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2275601405498944,"score_gpt":0.4898226120005154,"score_spread":0.262262471450621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}